ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OPTI Optibiotix Health Plc

18.125
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.125 17.75 18.50 18.125 18.125 18.13 63,107 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.38 16.52M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18.13p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.52 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.38.

Optibiotix Health Share Discussion Threads

Showing 20551 to 20572 of 147650 messages
Chat Pages: Latest  830  829  828  827  826  825  824  823  822  821  820  819  Older
DateSubjectAuthorDiscuss
07/2/2017
21:32
"100 million households consume Tata Salt each month"
someuwin
07/2/2017
21:19
"The story of the company is about harnessing the fruits of science for goals that go beyond business.

Serving society through science

A part of the over $100 billion Tata Group, Tata Chemicals Limited is a global company with interests in businesses that focus on essentials for LIFE: Living, Industry and Farm Essentials. The story of the company is about harnessing the fruits of science for goals that go beyond business.

Our story began in Mithapur, Gujarat, in western India in 1939 with a small plant that would raise a wealth of marine chemicals from the ocean. From these humble beginnings, Tata Chemicals has evolved into a market-leading international business, with operations across four continents, and businesses that touch the lives of millions across the globe. Our Innovation Centre, today, is home to world-class R&D capabilities in nanotechnology and biotechnology."

What a fantastic business for little ol' OPTI to be partnered with...

parob
07/2/2017
21:18
"Prebiotics could be one of the most promising but least understood ingredients in the supplements aisle. ................


........Market forecasters are very optimistic about prebiotics, too. Market researcher Grand View Research estimates that the global prebiotics market will reach $7.11 billion by 2024, citing “rising investment in the food and beverage industry for innovation and development of new food products enriched with prebiotics.”

maxwellsdemon
07/2/2017
21:08
Expect some housekeeping in the form of new trademarks, currently 16 with more being filed this week, which tie in with commercialisation. These have not been updated via the OPTI site (7), presumably as they are deemed non price sensitive, but my gut tells me this is more likely down to clues to commercial contracts signed or close to being signed off.
elrico
07/2/2017
20:30
That that's the same guy who thinks jim laird has over 800k shares left when he only ever had 333,000 from the beginning...Just saying I wouldn't be so certain re seller. Seneca were the only institutions selling last year who eventually got taken out. Yorkshire fund sold one tranch the day after brexit
riskybusiness1
07/2/2017
20:28
IMHO the recent 300k+ of orderly sales has been Laird disposing of his recently converted options through the company broker.
john henry
07/2/2017
20:08
re 19690, good old Rajiv Chandan, i hear he is one of the best, a very decent bloke, i am led to believe.
neftanikoff
07/2/2017
20:04
Parob, old mate, think apart from yourself, understandably some are already fully loaded, just look at share graph for the last 18months, no ammo for top ups, there are 2 sides to a story, think on
neftanikoff
07/2/2017
19:15
If you look at the positive, whoever has been selling has given many investors a little more time to top up before the next leg up. Many off this board inc. rafboy, 1bokke, lodger, marnewton, shrewdmole and me to name a few have taken advantage. Once we're over £1 I doubt we'll be dropping down here again. If you're a long-term investor why the rush for a higher price now? Take advantage while you can, we won't be at these prices forever!
parob
07/2/2017
19:10
The same selling pattern for the past 14 months...orderly selling of large chunks! Now who it is would be great/ my guess would be more IPO shares from seedcorn? Why? Well because they're 600% up! Could they also be raising funds to join in with the skinbiotix IPO? We shall see!
f3rdinand
07/2/2017
19:03
Parob 100k was sold on ISDX today.
john henry
07/2/2017
19:00
Parob seems to agree with me, ref 2 delayed largish deals are sells and is a no brainer really, think about it, together with all the very many buys and paper tip, if these had also been buys, then the share price would have been in the region of 85p plus, imo, with special mention on this to 1bokke and risky business. Now wouldn't it be good to know why sell at this time, maybe it is that former director getting rid of some more (did someone say he os not well) or even the one that got the 'sack'

PS parob, coming up from 60p is is ok, but nothing to write home about, especially from where the share price was last year, albeit it had run away of itself, a bit.

neftanikoff
07/2/2017
18:41
We can't be absolutely sure but it looks like 1 X 125K block and 1 X 75K block were sold yesterday but we were still up 5% on high volume.

We can still rise even with decent sized blocks being sold as they have been from 60p upwards. Stating the obvious, as long as the buys outnumber sells we'll keep rising!

Great to hear we have strong key opinion leader support for our LP-LDL strain during the interview. That will really help in getting these products noticed.

parob
07/2/2017
18:29
That trade yesterday looks more like a buy to me looking at price action yesterday and other trades around that time. How can you be sure?
riskybusiness1
07/2/2017
18:20
Excellent interview today. However large seller back in the market. Large sells been going through LSE and ISDX the past 3-4 days.
john henry
07/2/2017
18:13
Directors Talk.

Brilliant..must see it. For me..

Slimbione...Good sales growth and consumer validation with a lot of repeat sales.
Tata..confirmed Tata chemicals with 100$billion annual revenue.."First of a number of agreements". Products on sale 2nd half 2017.
LPDL...Multi product opportunity with a number of partners, to maximise shareholder return.

Sugars..60-70% sweetness of normal sugar market late 2017/early 2018. "Potential for rapid acceleration of company growth"..Steven O'Hara.

and .....3.2 Million in the bank.

belgrano2
07/2/2017
18:12
Very nice delayed trade showing up from this morning..
1bokke
07/2/2017
18:12
Shrewdmole, just a bit that little discussion on deals that you and F3rdinand and myself were having yesterday, when i bile thee were many more buys than sells and yet no price reaction after the initial up movement gained from the PSL tip, i thought there might be a delayed sell and it has now gone through, 125K from yesterday morning. Now i don't know how a chartist such as above can logistically account for such sells. We have the it over the weekend, we have expected news on several fronts, we have the official declaration of a serious partner (unfortunately not rns'd, i don't why not) and yet someone sells a chunk and so 1 individual stops what should be a more substantial rise. 1) why sell? and 2)_ how can a chartist legislate for such an occurrence?
neftanikoff
07/2/2017
18:00
Now I have a bit more time, here's the log scale daily candlestick chart:




From earlier:

Having broken out of the triple bottom the indicators were a bit toppy. OPTI has been consolidating to ameliorate the overbought condition and back-testing said breakout.

The consolidation pattern could be seen as a bull flag which will give a minimum target of just short of 100.00p. To confirm both the back-test and the flag we need to breach the recent high of 82.00p.

marnewton
07/2/2017
17:55
I have now listened to the interview. As usual with soh, it is a very good listen and he says ' hopefully there is a lot more to come in the coming weeks and months, the company having changed from R & D in 2016 to present product making with early revenues.

In my view there is nothing like a RNS giving the partner name as TATA Chemical, part of TATA with 60,000 employees and did he say £1billion in revenues company. All right it would not have given actual revenue details, but even so mentioning a partner like them to put this opti slim biome patented formula in their products would have given the share price a great fillip, imo. I hope there is a RNS on this along with any other share price enhancing information. I am not sure when he said Tata products will be on the shelves.

Still on slimbiome, he does indeed say that he hopes to have this formula in products that you can buy in the like of Boots, Waitrose, Sainsburys, etc., will this be the same GoFigure shakes and bars that are sold direct from GoFigure and other internet places like Amazon and Superfoods as well as pharmacies in the country Iceland and other selected pharmacies in the UK?

With regard to the Cholesterol product, we have heard again that there has been a lot of interest with wide range of partners, products due spring 2017. Multiple revenues from Manufacturers, distributors ad sales, with a range of multiple partners.However, there was no specific mention of MN, P & G. I am really interested to receive a RNS on this one.

As for the 'sweet natural' sugar products, these are to come later this year or early 2018.

And CASH IN BANK IS £3.2M. This together with opti not going alone, please note M'mouse and his various clones.

neftanikoff
07/2/2017
17:07
Sales of cholesterol treating medicines was €35 billion in 2010...will be interesting to hear about their plans for a pharma product going forwards!
f3rdinand
07/2/2017
17:00
If our cholesterol/BP reducing products show similar efficacy to the lab tests, then it'll become a market leader and be sold all over the world in no time: creating massive revenues! There's nothing like it out there and cholesterol is a health issue that is not going away any time soon! Add to that the fears about Statins and the media will be all over our products!! Well that's the 'dream' scenario!
f3rdinand
Chat Pages: Latest  830  829  828  827  826  825  824  823  822  821  820  819  Older

Your Recent History

Delayed Upgrade Clock